The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD)

Endokrynologia Polska

Volumn 65, Issue 2, 2014, Pages 150-155

  Mikoś, Hanna ^a   Mikoś, Marcin ^a   Obara Moszyńska, Monika ^a   Niedziela, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anti thyroid antibodies; Autoimmune thyroid disease; Cytokines; T cells; Thyroid

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; PROSTAGLANDIN; THYROGLOBULIN; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; FUNCTIONAL DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INFLAMMATION; PHENOTYPE; PROSTAGLANDIN SYNTHESIS; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; THYROID FOLLICLE CELL; ANIMAL; IMMUNOLOGY;

ANIMALS; CYTOKINES; HUMANS; THYROIDITIS, AUTOIMMUNE;

EID: 84901391203     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: 10.5603/EP.2014.0021     Document Type: Review

References (53)

1. Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; 148: 1-9. (Pubitemid 36175997)
2. Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 2002; 29 (Suppl. 2): 417-424.
3. Crivellato E, Vacca A, Ribatti D. Setting the stage: an anatomist's view of the immune system. Trends Immunol 2004; 25: 210-217. (Pubitemid 38368168)
4. Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008; 30: 58-62.
5. Sakaguchi S, Yamaguchi T, Nomura T et al. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787. (Pubitemid 351707693)
6. Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000; 18: 423-449. (Pubitemid 30365387)
7. Weaver CT, Harrington LE, Mangan PR et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-688. (Pubitemid 43867371)
8. Berger A. Th1 and Th2 responses: what are they? BMJ 2000; 321: 424.
9. Wang SH, Baker JR. The role of apoptosis in thyroid autoimmunity. Thyroid 2007; 17: 975-979. (Pubitemid 350071601)
10. Salmaso C, Bagnasco M, Pesce G, Montagna P et al. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann N Y Acad Sci 2002; 966: 496-501. (Pubitemid 34729212)
11. Giordano C, Stassi G, De Maria R et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-963. (Pubitemid 27087708)
12. Bretz JD, Baker JR Jr. Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? Clin Endocrinol (Oxf) 2001; 55: 1-11. (Pubitemid 34204292)
13. Giordano C, Richiusa P, Bagnasco M et al. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 2001; 11: 233-244. (Pubitemid 32298420)
14. Nagayama Y. Graves' animal models of Graves' hyperthyroidism. Thyroid 2007; 17: 981-988. (Pubitemid 350071594)
15. Traves SL, Donnelly LE. Th17 cells in airway diseases. Curr Mol Med 2008; 8: 416-426.
16. Nanba T, Watanabe M, Inoue N et al. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 2009; 19: 495-501.
17. Figueroa-Vega N, Alfonso-Perez M, Benedicto I et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2010; 95: 953-962.
18. Idźkowska E, Bossowski A, Noiszewska K et al. Analiza stȩżenia IL-17 i IL-23 w dynamice chorób autoimmunizacyjnych tarczycy u młodocianych. Endokrynologia Pediatryczna 2012; 3: 17-26.
19. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352.
20. Nakano A, Watanabe M, Iida T et al. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid 2007; 17: 25-31. (Pubitemid 46214719)
21. Fu S, Yopp AC, Mao X et al. CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004; 4: 65-78. (Pubitemid 38155491)
22. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061. (Pubitemid 36222930)
23. Tsatsoulis A. The role of stress in the clinical expression of thyroid autoimmunity. Ann N Y Acad Sci 2006; 1088: 382-395. (Pubitemid 47092036)
24. Phenekos C, Vryonidou A, Gritzapis AD et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004; 11: 209-213. (Pubitemid 38916092)
25. Caturegli P. Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab 2007; 92: 2038-2040. (Pubitemid 46997097)
26. Belyavin G, Trotter WR. Investigations of thyroid antigens reacting with Hashimoto sera; evidence for an antigen other than thyroglobulin. Lancet 1959; 1: 648-652.
27. Prummel MF, Wiersinga WM. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab 2005; 19: 1-15. (Pubitemid 40253946)
28. Fink H, Hintze G. Autoimmune thyroiditis (Hashimoto's thyroiditis): current diagnostics and therapy. Med Klin (Munich) 2010; 105: 485-493.
29. Czarnocka B, Janota-Bzowski M, McIntosh RS et al. Immunoglobulin G kappa antithyroid peroxidase antibodies in Hashimoto's thyroiditis: epitope-mapping analysis. J Clin Endocrinol Metab 1997; 82: 2639-2644. (Pubitemid 27337886)
30. Berthold H, Steffens U, Northemann W. Human thyroid peroxidase: autoantibody recognition depends on the natural conformation. J Clin Lab Anal 1993; 7: 401-404. (Pubitemid 23340496)
31. Jastrzebska-Bohaterewicz E, Gardas A. Proportion of antibodies to the A and B immunodominant regions of thyroid peroxidase in Graves and Hashimoto disease. Autoimmunity 2004; 37: 211-216. (Pubitemid 39162677)
32. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499. (Pubitemid 34158210)
33. Bar-Andziak E, Milewicz A, Jedrzejuk D et al. Thyroid dysfunction and thyroid autoimmunity in a large unselected population of elderly subjects in Poland - the 'PolSenior' multicentre crossover study. Endokrynol Pol 2012; 63: 346-355.
34. Quadbeck B, Hoermann R, Hahn S, et al. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment. Horm Metab Res 2005; 37: 745-750. (Pubitemid 43028076)
35. Eckstein AK, Plicht M, Lax H et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006; 91: 3464-3470. (Pubitemid 44402120)
36. Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 1988; 9: 106-121.
37. Kamath C, Adlan MA, Premawardhana LD. The role of thyrotrophin receptor antibody assays in graves' disease. J Thyroid Res 2012; 2012: 525936.
38. Tozzoli R, Bagnasco M, Giavarina D et al. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmun Rev 2012; 12: 107-113.
39. Zophel K, Roggenbuck D, Schott M. Clinical review about TRAb assay's history. Autoimmun Rev 2010; 9: 695-700.
40. Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity 2003; 36: 351-359. (Pubitemid 37160523)
41. Ajjan RA, Watson PF, Weetman AP. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1997; 82: 666-669. (Pubitemid 27068648)
42. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000; 14: 23-42. (Pubitemid 30080536)
43. Ajjan RA, Watson PF, Weetman AP. Cytokines and thyroid function. Adv Neuroimmunol 1996; 6: 359-386. (Pubitemid 27249231)
44. Pedro AB, Romaldini JH, Takei K. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment. Neuroimmunomodulation 2011; 18: 45-51.
45. Natt N, Bahn RS. Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity 1997; 26: 129-136. (Pubitemid 27499612)
46. Rasmussen AK. Cytokine actions on the thyroid gland. Dan Med Bull 2000; 47: 94-114. (Pubitemid 30216806)
47. Hunt PJ, Marshall SE, Weetman AP. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 1984-1988. (Pubitemid 32269309)
48. Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 2008; 18: 953-958.
49. Ajjan RA, Watson PF, McIntosh RS et al. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol 1996; 105: 523-528. (Pubitemid 26297900)
50. O'Shea JJ, Visconti R. Type 1 IFNs and regulation of TH1 responses: enigmas both resolved and emerge. Nat Immunol 2000; 1: 17-19.
51. Nakagawa T, Tsuruoka M, Ogura H et al. IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int Immunol 2010; 22: 129-139.
52. Palazzo FF, Hammond LJ, Goode AW et al. Death of the autoimmune thyrocyte: is it pushed or does it jump? Thyroid 2000; 10: 561-572. (Pubitemid 30670616)
53. Krupinska J, Wawrzynowicz-Syczewska M, Urbanowicz W et al. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C. Endokrynol Pol 2011; 62: 517-522.